Stay updated on Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed on the page, replacing v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:21:54.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Administrative site updates: a new revision entry (v3.4.2) and removal of an older funding notice; these changes do not affect the study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:21:42.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government-funding notice banner indicating the NIH Clinical Center is open and where to check status updates (opm.gov). Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:28:48.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added results posting information and new outcomes for the study, including DFS definitions and adverse-event metrics with follow-up times, and linked a PDF of the Study Protocol and SAP. The page's study documents section was updated and some prior analysis details were removed.
    Difference
    3%
    Check dated 2026-01-28T06:28:40.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and the previous v3.3.3 revision was removed, representing a minor technical update with no changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:07:11.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new Locations section appears with Texas as a study site. The previous Texas Locations entry and the HHS Vulnerability Disclosure link were removed; the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:25:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page.